William Slattery

Company: O-Ray Pharma

Job title: Chief Executive Officer

Seminars:

Designing & Developing Novel Platform Technology for Sustained Release of Various Therapeutic Modalities via Cochlear Implant Device 9:30 am

Developing sustained release drug formulations delivered via implantable pellets embedded into the cochlea, on a cochlear implant electrode or in a hydrogel Understanding the FDA’s criteria for successful outcome measures for inner ear drug therapeutics and cochlear implants; device improvement and drug efficacy Reviewing regulatory discussions to gain approval for drug/device combination productsRead more

day: Conference Day 2

Panel Discussion: Developing Combination Therapy & Utilizing Cochlear Implants as Delivery Devices 4:00 pm

Understanding the limitations of using cochlear implants as the sole treatment Managing off-target effects and inflammatory responses by combining implants with drugs Discussing the challenges of delivering gene therapies vs cell therapies vs small molecules using implant devicesRead more

day: Conference Day 2